Enavate Sciences GP, LLC's Form 4 filing
Camp4 Therapeutics Corp (CAMP) · filed Oct 17, 2024
- Accession no.
- 0001415889-24-025354
- Filed
- Oct 17, 2024, 4:15 PM ET
- Trade date
- Oct 15, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $15.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Enavate Sciences GP, LLCCIK 0001953107 | 10% Owner |
| Everest Aggregator, LPCIK 0002040426 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | CConversionAcquired | +2,422,166 | – | – | 2,422,166 | Indirect | |
| Oct 15, 2024 | Common Stock | PPurchaseAcquired | +1,363,636 | $11.00 | +$14,999,996 | 3,785,802 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | CConversionDisposed | −2,422,166 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.